News
CAMBRIDGE, Mass., June 4, 2025 /PRNewswire/ -- MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback